HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-(Methylsulfonyl)pyrido[2,3-d]pyrimidin-7(1H)-one → 2-[4-(4-Naphthalen-1-yl-piperazin-1-yl)-butoxy]-8H-pyrido[2,3-d]pyrimidin-7-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-(Methylsulfonyl)pyrido[2,3-d]pyrimidin-7(1H)-one | HCID 18374934 | — |
| Reactant | 4-(4-Naphthalen-1-yl-piperazin-1-yl)-butan-1-ol | HCID 21073352 | — |
| Product | 2-[4-(4-Naphthalen-1-yl-piperazin-1-yl)-butoxy]-8H-pyrido[2,3-d]pyrimidin-7-one | HCID 21073240 | — |
Reaction Steps
Following the same procedure as in Example H12 and starting from 2-methanesulfonyl-8H-pyrido[2,3-d]pyrimidin-7-one (300 mg, 1.332 mmol, U.S. Pat. No. 6,498,163) and 4-(4-naphthalen-1-yl-piperazin-1-yl)-butan-1-ol (416 mg, 1.465 mmol), the title compound was made as a solid (300 mg, 0.683 mmol, 51.3%). MS: APCI: M+1: 430.2 (Exact Mass: 429.22).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07160888B2 |
| Source dataset | uspto-grants-2007_01 |
| ORD ID | ord-8b004516384b42ecb7c0482d8e0b0525 |
| Source note | uspto-grants-2007_01 |